T1	Entity 354 390	small-effect quantitative trait loci
T2	Entity 392 395	QTL
T3	KeyEntity 400 426	collagen induced arthritis
T4	KeyEntity 428 431	CIA
T5	Entity 503 526	genome linkage analysis
T6	Entity 638 662	gene expression patterns
T7	Entity 771 792	genomic region linked
T8	Entity 810 826	disease-specific
T9	Entity 877 892	strain-specific
T10	Entity 989 1001	CIA severity
T11	Entity 954 976	Eight small-effect QTL
T12	Entity 1205 1223	8 small-effect QTL
R1	other_relation Arg1:T2 Arg2:T1	
#1	AnnotatorNotes R1	equivalent
R2	other_relation Arg1:T4 Arg2:T3	
#2	AnnotatorNotes R2	equivalent
R3	participates_in Arg1:T11 Arg2:T10	
T13	KeyEntity 10 23	global genome
T14	KeyEntity 28 41	transcriptome
T15	Entity 69 124	candidate genes of small-effect quantitative trait loci
R4	interacts_with Arg1:T13 Arg2:T15	
R5	interacts_with Arg1:T14 Arg2:T15	
T16	KeyEntity 128 154	collagen-induced arthritis
T17	KeyEntity 548 551	CIA
T18	Entity 600 616	small-effect QTL
T19	KeyEntity 439 452	global genome
T20	KeyEntity 457 470	transcriptome
T21	KeyEntity 686 689	CIA
T22	KeyEntity 859 862	CIA
T23	KeyEntity 796 799	CIA
T24	KeyEntity 1128 1131	CIA
T25	KeyEntity 2313 2345	collagen-induced arthritis (CIA)
T26	Entity 2446 2458	CIA severity
T27	Entity 2529 2547	CIA susceptibility
T28	KeyEntity 5070 5073	CIA
T30	Entity 5278 5301;5324 5331	CIA susceptible (DBA/1) strains
T32	KeyEntity 5559 5562	CIA
T36	KeyEntity 6223 6226	CIA
T37	KeyEntity 6687 6690	CIA
T38	KeyEntity 6983 6986	CIA
T39	KeyEntity 8098 8101	CIA
T41	KeyEntity 10376 10379	CIA
T43	KeyEntity 10834 10837	CIA
T44	KeyEntity 11150 11165	CIA development
T45	Entity 11513 11525	CIA severity
T46	Entity 12421 12429;12433 12436	severity CIA
T47	KeyEntity 13914 13917	CIA
T48	KeyEntity 14208 14211	CIA
T49	Entity 14732 14745	CIA induction
T50	KeyEntity 14890 14893	CIA
T51	KeyEntity 14966 14969	CIA
T52	KeyEntity 15467 15470	CIA
T53	KeyEntity 15725 15728	CIA
T54	KeyEntity 15824 15827	CIA
T55	KeyEntity 16010 16013	CIA
T56	KeyEntity 16091 16100;16104 16107	induction CIA
T57	KeyEntity 16375 16388;16392 16395	chronic phase CIA
T58	KeyEntity 17244 17264	CIA small-effect QTL
T60	Entity 18309 18322;18326 18329	chronic phase CIA
T61	KeyEntity 18486 18489	CIA
T62	Entity 18650 18653	CIA
T63	KeyEntity 19444 19464;19469 19472	susceptibility genes CIA
T64	Entity 20611 20623	CIA severity
T65	KeyEntity 20895 20898	CIA
T66	Entity 20961 20973	CIA severity
T67	KeyEntity 21096 21099	CIA
T68	KeyEntity 21233 21236	CIA
T69	KeyEntity 21385 21388	CIA
T70	Entity 21940 21975	early phases of CIA (NC, PI and OA)
T71	KeyEntity 22266 22269	CIA
T72	KeyEntity 22503 22506	CIA
T73	Entity 22695 22716	susceptibility to CIA
T74	KeyEntity 22891 22894	CIA
T75	KeyEntity 23457 23460	CIA
T76	KeyEntity 24982 24985;24986 25000	CIA susceptibility
T77	KeyEntity 25500 25503	CIA
T78	Entity 26617 26630	stages of CIA
T79	Entity 26632 26634	NA
T80	Entity 26636 26638	PI
T81	Entity 26640 26642	OA
T82	Entity 26647 26649	CA
R6	is_part_of Arg1:T79 Arg2:T78	
R7	is_part_of Arg1:T80 Arg2:T78	
R8	is_part_of Arg1:T81 Arg2:T78	
R9	is_part_of Arg1:T82 Arg2:T78	
T83	KeyEntity 27072 27075	CIA
T84	KeyEntity 27608 27611	CIA
T85	Entity 27933 27977;27992 27999	collagen-induced arthritis (CIA) susceptible strains
T86	Entity 27933 27965;27982 27999	collagen-induced arthritis (CIA) resistant strains
T87	KeyEntity 28093 28099;28103 28106	phases CIA
T88	KeyEntity 28208 28214;28218 28221	phases CIA
T89	KeyEntity 28513 28519;28523 28526	phases CIA
T90	KeyEntity 28597 28629	collagen-induced arthritis (CIA)
T91	KeyEntity 28926 28929	CIA
T92	KeyEntity 29590 29593	CIA
T93	Entity 1411 1436	rheumatoid arthritis (RA)
T94	Entity 1447 1488	complex multifactorial autoimmune disease
R10	is_subclass_of Arg1:T93 Arg2:T94	
T95	Entity 1542 1555;1559 1561	genetic basis RA
T96	Entity 1580 1595	genomic regions
T97	Entity 1657 1672	genomic regions
T98	Entity 1830 1832	RA
T99	Entity 1834 1861	Small genetic contributions
T100	Entity 1890 1910;1914 1916	susceptibility genes RA
T101	Entity 1946 1953	HLA-DR4
T102	Entity 1955 1960	PADI4
T103	Entity 1962 1968	PTPN22
T104	Entity 1973 1978	FCRL3
R11	is_subclass_of Arg1:T101 Arg2:T100	
R12	is_subclass_of Arg1:T102 Arg2:T100	
R13	is_subclass_of Arg1:T103 Arg2:T100	
R14	is_subclass_of Arg1:T104 Arg2:T100	
T105	Entity 1997 2004	HLA-DR4
T106	Entity 2040 2042	RA
R15	regulates Arg1:T105 Arg2:T106	
T107	Entity 2058 2078	susceptibility genes
T108	Entity 2127 2138;2142 2144	mouse model RA
T109	Entity 2146 2173	small genetic contributions
T110	Entity 2250 2263	genome screen
T111	Entity 2280 2309	quantitative trait loci (QTL)
T112	Entity 2370 2382;2386 2388	animal model RA
T113	Entity 2399 2402	QTL
T114	Entity 2404 2408	Cia2
R16	is_subclass_of Arg1:T114 Arg2:T113	
R17	regulates Arg1:T114 Arg2:T26	
T115	Entity 2469 2472	QTL
T116	Entity 2607 2627	susceptibility genes
T117	Entity 2972 2992	susceptibility genes
T118	Entity 3085 3088	QTL
T119	Entity 3117 3129	mouse genome
T120	Entity 3146 3149	QTL
T121	Entity 3227 3258	quantitative trait genes (QTGs)
T122	Entity 3266 3278	mouse genome
T123	Entity 3328 3332	QTGs
T124	Entity 3370 3390	causal polymorphisms
T125	Entity 3398 3419	protein-coding region
T126	Entity 3440 3465	protein structure changes
T127	Entity 3469 3487	protein deficiency
T128	Entity 3526 3542	small-effect QTL
T129	Entity 3630 3643	polymorphisms
T130	Entity 3655 3670	gene expression
R18	regulates Arg1:T129 Arg2:T130	
T131	Entity 3765 3804	Microarray-based global gene expression
T132	Entity 4046 4065	expression patterns
T133	Entity 4073 4102	disease-related cells/tissues
T134	Entity 4199 4201	RA
T135	Entity 4259 4268	arthritis
T136	Entity 4274 4302	distinct expression patterns
T137	Entity 4380 4398	immunoinflammatory
T138	Entity 4446 4457	blood cells
T139	Entity 4461 4463	RA
T140	Entity 4479 4489	Chemokines
T141	Entity 4494 4512	adhesion molecules
T142	Entity 4537 4542	joint
T143	Entity 4550 4566;4570 4579	initiation phase arthritis
T144	Entity 4612 4617;4630 4651	genes cartilage destruction
T145	Entity 4612 4617;4656 4668	genes bone erosion
R19	participates_in Arg1:T140 Arg2:T143	
R20	participates_in Arg1:T141 Arg2:T143	
T146	Entity 4706 4716;4720 4729	late phase arthritis
T147	Entity 4733 4746;4750 4752	animal models RA
R21	participates_in Arg1:T145 Arg2:T146	
R22	participates_in Arg1:T144 Arg2:T146	
T148	Entity 4816 4827	microarrays
T149	Entity 4861 4882	genetic polymorphisms
T150	Entity 4894 4909	gene expression
R23	regulates Arg1:T149 Arg2:T150	
T151	Entity 4988 5000	polymorphism
T152	Entity 5012 5031	regulatory elements
T153	Entity 5050 5066	small-effect QTL
T154	Entity 5089 5114	potential candidate genes
R24	is_part_of Arg1:T154 Arg2:T153	
T29	Entity 5144 5171;5186 5193	CIA genetically susceptible strains
T155	Entity 5144 5159;5176 5193	CIA genetically resistant strains
T156	Entity 5206 5212	genome
T157	KeyEntity 5217 5230	transcriptome
T158	Entity 5246 5252	genome
T31	Entity 5278 5281;5306 5331	CIA resistant (FVB/N) strains
T159	KeyEntity 5353 5381	genome-wide linkage analysis
T160	Entity 5408 5424	small-effect QTL
T161	KeyEntity 5433 5446	transcriptome
T162	KeyEntity 24415 24428	transcriptome
T163	Entity 5470 5494	gene expression patterns
T164	Entity 5507 5512	DBA/1
T165	Entity 5517 5522	FVB/N
T166	Entity 5568 5593	potential candidate genes
T33	Entity 5664 5691	enomic region linked to CIA
T34	Entity 5702 5754	disease-specific differentially expressed during CIA
T167	Entity 5769 5809;5850 5853	strain-specific differentially expressed CIA
T35	Entity 5888 5900	immunisation
T168	Entity 5919 5928	arthritis
T169	Entity 5935 5940	DBA/1
T170	Entity 5945 5950	FVB/N
T171	Entity 6347 6353	DBA/1J
T172	Entity 6355 6360	FVB/N
T173	Entity 6365 6391	(DBA/1J × FVB/N)F2 progeny
T174	Entity 6692 6713	Arthritis development
T175	Entity 6754 6772	three-score system
T176	Entity 6614 6626	immunisation
T177	Entity 6580 6589	arthritis
T178	Entity 6828 6833	FVB/N
T179	Entity 6838 6844	DBA/1J
T180	Entity 6868 6877;6881 6896	detection gene expression
T181	Entity 6995 7013	naive control (NC)
T182	Entity 7015 7037	post-immunisation (PI)
T183	Entity 7039 7062	onset of arthritis (OA)
T184	Entity 7067 7089	chronic arthritis (CA)
T185	Entity 7105 7107	NC
T186	Entity 7203 7205	PI
T187	Entity 7244 7256	immunisation
T188	Entity 7274 7276	OA
T189	Entity 7315 7327	immunisation
T190	Entity 7335 7359	FVB/N non-arthritic mice
T191	Entity 7370 7375	DBA/1
T192	Entity 7402 7411	arthritis
T193	Entity 7434 7446	immunisation
T194	Entity 7479 7491	immunisation
T195	Entity 7509 7511	CA
T196	Entity 7550 7562	immunisation
T197	Entity 7570 7589	non-arthritic FVB/N
T198	Entity 7605 7615	DBA/1 mice
T199	Entity 7635 7644	arthritis
T200	Entity 7705 7706	n
T201	Entity 7716 7732	Linkage analysis
T202	Entity 7776 7789	genome screen
T203	Entity 7871 7905	informative microsatellite markers
T204	Entity 1689 1722	genome-wide significant threshold
T205	Entity 7919 7925	genome
T206	Entity 10449 10462	genome screen
T207	Entity 12180 12204	syntenic genomic regions
T208	Entity 12212 12224	human genome
T209	Entity 12327 12339	mouse genome
T210	Entity 12801 12813	human genome
T211	Entity 19943 19955	human genome
T212	Entity 24156 24162	genome
T213	Entity 25544 25556	human genome
T214	Entity 7999 8015	linkage analyses
T215	Entity 8103 8121	arthritis severity
T216	Entity 8161 8177	small-effect QTL
T217	Entity 8273 8297	microarray hybridisation
T218	Entity 8299 8316	Lymph nodes (LNs)
T219	Entity 8330 8347	immunisation site
T220	Entity 8362 8383	total RNA preparation
T221	Entity 8389 8398	total RNA
T222	Entity 8422 8440	tissue homogenates
T223	Entity 8531 8539;8543 8558	Analysis gene expression
T40	Entity 10356 10372	Small-effect QTL
T224	Entity 10383 10409	(DBA/1 × FVB/N) F2 progeny
T42	Entity 10475 10509	QTL controlling CIA susceptibility
T225	Entity 10513 10539	(DBA/1 × FVB/N) F2 progeny
T226	Entity 10562 10580	arthritis severity
T227	Entity 10591 10594	QTL
T228	Entity 10596 10600	Cia2
R25	is_subclass_of Arg1:T228 Arg2:T227	
T229	Entity 10699 10703	Cia2
T230	Entity 10794 10810	small-effect QTL
T231	Entity 10939 10955	small-effect QTL
T232	Entity 11083 11087	Cia2
T233	Entity 11089 11117	complement component C5 (Hc)
R26	is_part_of Arg1:T233 Arg2:T232	
R27	regulates Arg1:T233 Arg2:T44	
T234	Entity 11182 11187	FVB/N
T235	Entity 11198 11210	C5 deficient
T236	Entity 11225 11241	small-effect QTL
T237	Entity 11261 11265	Cia2
T238	Entity 11282 11296;11300 11302	masking effect C5
T239	Entity 11317 11333	linkage analysis
T240	Entity 11380 11390	F2 progeny
T241	Entity 11406 11422	C5+/+ F2 progeny
T242	Entity 11437 11457	133 C5+/- F2 progeny
T243	Entity 11465 11480	genomic regions
T244	Entity 12257 12266	arthritis
T245	Entity 11609 11625	small-effect QTL
T246	Entity 11763 11768	DBA/1
T247	Entity 11776 11797	susceptibility allele
T248	Entity 11813 11818	FVB/N
T249	Entity 11826 11847	susceptibility allele
R28	is_subclass_of Arg1:T246 Arg2:T247	
R29	is_subclass_of Arg1:T248 Arg2:T249	
T250	Entity 12024 12042	false negative QTL
T251	Entity 12072 12090	false positive QTL
T252	Entity 12131 12146	genomic regions
T253	Entity 12273 12289	small-effect QTL
T254	Entity 12306 12319	arthritis QTL
T255	Entity 12390 12395	Cia13
T256	Entity 12400 12405	Cia14
T257	Entity 12440 12467	(DBA/1 × BALB/C) F2 progeny
R30	regulates Arg1:T255 Arg2:T46	
R31	regulates Arg1:T256 Arg2:T46	
T258	Entity 12521 12525	Cia8
T259	Entity 12493 12506	chromosome 10
R32	is_part_of Arg1:T258 Arg2:T259	
T260	Entity 12551 12577	(DBA/1 × B10.Q) F2 progeny
T261	Entity 12606 12611	Pgia7
T262	Entity 12628 12683	susceptibility to proteoglycan-induced arthritis (PGIA)
R33	regulates Arg1:T261 Arg2:T262	
T263	Entity 12706 12733	(BALB/C × DBA/2) F2 progeny
T264	Entity 12744 12768	syntenic genomic regions
T265	Entity 12777 12793	small-effect QTL
T266	Entity 12849 12851	RA
T267	Entity 12863 12878	genomic regions
T268	Entity 12879 12884	22q11
T269	Entity 12889 12898	12p13-q24
R34	is_subclass_of Arg1:T268 Arg2:T267	
R35	is_subclass_of Arg1:T269 Arg2:T267	
T270	Entity 12902 12915	chromosome 22
T271	Entity 12902 12912;12920 12922	chromosome 12
R36	is_part_of Arg1:T268 Arg2:T270	
R37	is_part_of Arg1:T269 Arg2:T271	
T272	Entity 12954 12981	12p13-pter on chromosome 12
T273	Entity 13012 13022	21q22-qter
T274	Entity 13027 13035	10q22-23
T275	Entity 13039 13052	chromosome 21
T276	Entity 13039 13049;13057 13059	chromosome 10
T277	Entity 13091 13116	17q21-25 on chromosome 17
T278	Entity 13150 13175	3q29-qter on chromosome 3
R38	is_subclass_of Arg1:T272 Arg2:T267	
R39	is_subclass_of Arg1:T273 Arg2:T267	
R40	is_subclass_of Arg1:T274 Arg2:T267	
R41	is_subclass_of Arg1:T277 Arg2:T267	
R42	is_subclass_of Arg1:T278 Arg2:T267	
R43	is_part_of Arg1:T273 Arg2:T275	
R44	is_part_of Arg1:T274 Arg2:T276	
T279	Entity 13213 13259	Strain-specific differentially expressed genes
T280	Entity 13277 13301	gene expression profiles
T281	Entity 13764 13810	strain-specific differentially expressed genes
T282	Entity 13825 13836;13840 13855	comparisons gene expression
T283	Entity 13868 13873	DBA/1
T284	Entity 13878 13883	FVB/N
T285	Entity 13929 13931	NC
T286	Entity 13933 13935	PI
T287	Entity 13937 13939	OA
T288	Entity 13944 13946	CA
R45	other_relation Arg1:T285 Arg2:T47	
#3	AnnotatorNotes R45	is_a_phase_of
R46	other_relation Arg1:T286 Arg2:T47	
#4	AnnotatorNotes R46	is_a_phase_of
R47	other_relation Arg1:T287 Arg2:T47	
#5	AnnotatorNotes R47	is_a_phase_of
R48	other_relation Arg1:T288 Arg2:T47	
#6	AnnotatorNotes R48	is_a_phase_of
T289	Entity 15028 15030	PI
T290	Entity 15032 15034	OA
T291	Entity 15039 15041	CA
T292	Entity 15066 15068	NC
T293	Entity 15555 15557	PI
T294	Entity 15563 15565	OA
T295	Entity 15567 15569	PI
T296	Entity 15575 15577	CA
T297	Entity 15582 15584	OA
T298	Entity 15590 15592	CA
T299	Entity 15732 15742	DBA/1 mice
R49	other_relation Arg1:T181 Arg2:T38	
#7	AnnotatorNotes R49	is_a_phase_of
R50	other_relation Arg1:T182 Arg2:T38	
#8	AnnotatorNotes R50	is_a_phase_of
R51	other_relation Arg1:T183 Arg2:T38	
#9	AnnotatorNotes R51	is_a_phase_of
R52	other_relation Arg1:T184 Arg2:T38	
#10	AnnotatorNotes R52	is_a_phase_of
T300	Entity 11642 11655	chromosomes 5
T301	Entity 11642 11653;11657 11658	chromosomes 6
T302	Entity 11642 11653;11663 11665	chromosomes 10
T303	Entity 11642 11653;11660 11661	chromosomes 7
T304	Entity 11642 11653;11667 11669	chromosomes 11
T305	Entity 11642 11653;11671 11673	chromosomes 16
T306	Entity 11642 11653;11679 11681	chromosomes 17
T307	Entity 13956 13987	naive mice without immunisation
T308	Entity 14070 14082	immunisation
T309	Entity 14187 14197	DBA/1 mice
T310	Entity 14224 14254	differentially expressed genes
T311	Entity 14304 14309;14322 14328	onset phases
T312	Entity 14314 14328	chronic phases
T313	Entity 14366 14396	differentially expressed genes
T314	Entity 14665 14705	strain-specific differentially expressed
T315	Entity 14747 14749	PI
T316	Entity 14751 14753	OA
T317	Entity 14758 14760	CA
R53	other_relation Arg1:T315 Arg2:T49	
#11	AnnotatorNotes R53	is_a_phase_of
R54	other_relation Arg1:T316 Arg2:T49	
#12	AnnotatorNotes R54	is_a_phase_of
R55	other_relation Arg1:T317 Arg2:T49	
#13	AnnotatorNotes R55	is_a_phase_of
T318	Entity 14774 14821	Disease-specific differentially expressed genes
T319	Entity 14839 14886	disease-specific differentially expressed genes
T320	Entity 14955 14958	LNs
T321	Entity 14977 14995	susceptible strain
T322	Entity 15092 15104	immunisation
T323	Entity 15209 15220	onset phase
T324	Entity 15289 15302	chronic phase
T325	Entity 15640 15687	disease-specific differentially expressed genes
T326	Entity 15793 15816	gene expression pattern
T327	Entity 15842 15871	hierarchical cluster analysis
T328	Entity 15897 15910	gene clusters
T329	Entity 15970 16002	distinct gene expression pattern
T330	Entity 16161 16172	onset phase
T331	Entity 16192 16213	functional clustering
T332	Entity 16260 16275	immune response
T333	Entity 16435 16450	immune response
T334	Entity 16452 16470	organelle membrane
T335	Entity 16475 16495	extracellular region
T336	Entity 16475 16488;16500 16505	extracellular space
T337	Entity 16571 16579	PI phase
T338	Entity 16612 16634	intercellular junction
T339	Entity 16752 16765	chronic phase
T340	Entity 16807 16831	lymphocyte proliferation
T341	Entity 16833 16850	T cell activation
T342	Entity 16852 16867	protein binding
T343	Entity 16883 16903	notch signal pathway
T344	Entity 16957 16965	PI phase
T345	Entity 17017 17025	OA phase
T347	KeyEntity 17168 17184;17188 17191	small-effect QTL CIA
T348	Entity 17205 17235	candidate susceptibility genes
T346	Entity 17144 17159	Candidate genes
T349	Entity 17290 17336	strain-specific differentially expressed genes
T350	Entity 17354 17401	disease-specific differentially expressed genes
T351	Entity 17556 17572	small-effect QTL
T352	Entity 17607 17618;17637 17639	chromosomes 16
T353	Entity 17607 17618;17633 17635	chromosomes 11
T354	Entity 17607 17618;17626 17627	chromosomes 7
T355	Entity 17607 17618;17623 17624	chromosomes 6
T356	Entity 17607 17618;17620 17621	chromosomes 5
T357	Entity 17607 17618;17629 17631	chromosomes 10
T358	Entity 17607 17618;17644 17646	chromosomes 17
T359	Entity 17682 17685	QTL
T360	Entity 17857 17860	QTL
T361	Entity 18003 18017	candidate gene
T362	Entity 18077 18092	candidate genes
T363	Entity 18130 18136	hspa1a
T364	Entity 18141 18146	Oas1a
T365	Entity 18172 18180;18184 18187	OA phase CIA
T59	Entity 18192 18197	Oas1a
T366	Entity 18226 18234	PI phase
T367	Entity 18349 18355	hspa1a
T368	Entity 18418 18426	NC phase
T369	Entity 18501 18507	H2-Q10
T370	Entity 18509 18515	Mapk14
T371	Entity 18517 18522	Pscd1
T372	Entity 18524 18529	Kpnb1
T373	Entity 18534 18538	Wdr1
T374	Entity 18564 18570	H2-Q10
T375	Entity 18615 18620	DBA/1
T376	Entity 18630 18635	FVB/N
T377	Entity 18720 18725	DBA/1
T378	Entity 18764 18766	NC
T379	Entity 18768 18770	PI
T380	Entity 18775 18777	OA
T381	Entity 18809 18822	chronic phase
T382	Entity 18824 18855	GO term classification analysis
T383	Entity 18874 18892	functional cluster
T384	Entity 17031 17053	GO term classification
T385	Entity 17064 17082	functional cluster
T386	Entity 18896 18918	protein kinase cascade
T387	Entity 18956 18971	candidate genes
T388	Entity 18978 18996	functional cluster
T389	Entity 19029 19035	Mapk14
T390	Entity 19037 19045	Mapk8ip3
T391	Entity 19047 19053	Stat5a
T392	Entity 19058 19063	Gna12
R56	is_part_of Arg1:T389 Arg2:T388	
R57	is_part_of Arg1:T390 Arg2:T388	
R58	is_part_of Arg1:T391 Arg2:T388	
R59	is_part_of Arg1:T392 Arg2:T388	
T393	Entity 19137 19153	small-effect QTL
T394	Entity 19160 19170	F2 progeny
T395	Entity 17689 17699	F2 progeny
T396	Entity 7983 7993	F2 progeny
T397	Entity 5260 5270	F2 progeny
T398	Entity 2551 2561	F2 progeny
T399	Entity 530 540	F2 progeny
T400	Entity 19172 19188	Small-effect QTL
T401	Entity 19412 19428	small-effect QTL
T402	Entity 19498 19514	linkage analysis
T403	Entity 19552 19561	F progeny
T404	Entity 19566 19582	C5+/+ F2 progeny
T405	Entity 19591 19607	C5+/- F2 progeny
T406	Entity 19627 19643	small-effect QTL
T407	Entity 19708 19711	QTL
T408	Entity 19743 19746	QTL
T409	Entity 19792 19805	arthritis QTL
T410	Entity 19872 19889	syntenic analysis
T411	Entity 19908 19935	counterpart genomic regions
T412	Entity 19979 19982	QTL
T413	Entity 19997 19999	RA
T414	Entity 20024 20040	small-effect QTL
T415	Entity 20045 20058	DBA/1 alleles
T416	Entity 20067 20094	arthritis-enhancing alleles
T417	Entity 20106 20118	FVBN alleles
T418	Entity 20127 20154	arthritis-enhancing alleles
T419	Entity 20174 20177	QTL
T420	Entity 20200 20220	susceptibility genes
T421	Entity 20241 20257	resistant strain
T422	Entity 20314 20335	arthritis-related QTL
T423	Entity 20365 20375	F2 progeny
T424	Entity 20414 20428	genomic region
T425	Entity 20432 20437	Cia27
T426	Entity 20441 20493	QTL controlling IgG2a antibody levels to collagen II
R60	other_relation Arg1:T425 Arg2:T426	
#14	AnnotatorNotes R60	equivalent
T427	Entity 20526 20529	QTL
T428	Entity 20544 20558	genomic region
T429	Entity 20643 20679	IgG2a antibody levels to collagen II
T430	Entity 20697 20710	chromosome 16
T431	Entity 20725 20728	Lp1
T432	Entity 20745 20769	lymphocyte proliferation
R61	is_part_of Arg1:T431 Arg2:T430	
R62	regulates Arg1:T431 Arg2:T432	
T433	Entity 20829 20842	chromosome 17
T434	Entity 20852 20872	lymphocyte adherence
R63	regulates Arg1:T433 Arg2:T434	
T435	Entity 20931 20947	small-effect QTL
T436	Entity 20994 21022	arthritis-related phenotypes
T437	Entity 21073 21088	gene expression
T438	Entity 21119 21125	joints
T439	Entity 21133 21146	target tissue
T440	Entity 21203 21218	gene expression
T441	Entity 21222 21225	LNs
R64	is_subclass_of Arg1:T438 Arg2:T439	
T442	Entity 21271 21295	gene expression patterns
T443	Entity 21299 21302	LNs
T444	Entity 21311 21334;21349 21356	genetically susceptible strains
T445	Entity 21311 21322;21339 21356	genetically resistant strains
T446	Entity 21407 21437	differentially regulated genes
T447	Entity 21470 21472	PI
T448	Entity 21477 21479	CA
T449	Entity 21619 21622	LNs
T450	Entity 21644 21646	PI
T451	Entity 21651 21653	CA
T452	Entity 21673 21675	OA
T453	Entity 21756 21767;21785 21791	susceptible strain
T454	Entity 21775 21791	resistant strain
T455	Entity 21913 21918	DBA/1
T456	Entity 21927 21932	FVB/N
T457	Entity 22019 22021	CA
T458	Entity 22029 22051	GO term classification
T459	Entity 22094 22118	lymphocyte proliferation
T460	Entity 22094 22104;22123 22133	lymphocyte activation
T461	Entity 22151 22162	lymphocytes
T462	Entity 22170 22175	DBA/1
T463	Entity 22220 22225	FVB/N
T464	Entity 22361 22373	immunisation
T465	Entity 22415 22430	immune response
T466	Entity 22455 22460	DBA/1
T467	Entity 22483 22488	FVB/N
T468	Entity 22553 22585	antibody response to collagen II
T469	Entity 22602 22607	DBA/1
T470	Entity 22631 22636	FVB/N
T471	Entity 22786 22801	candidate genes
T472	Entity 22823 22839	small-effect QTL
T473	Entity 22859 22883	gene expression patterns
T474	Entity 22905 22922	genomic locations
T475	Entity 22927 22942	candidate genes
T476	Entity 22959 22962	QTL
T477	Entity 22988 23005	QTG polymorphisms
T478	Entity 23013 23033	susceptibility genes
T479	Entity 23051 23054	QTL
R65	is_part_of Arg1:T478 Arg2:T479	
T480	Entity 23100 23115	gene expression
T481	Entity 24511 24526	gene expression
T482	Entity 28019 28034	gene expression
T483	Entity 28047 28052	DBA/1
T484	Entity 28057 28062	FVB/N
T485	Entity 29043 29067	relative gene expression
T486	Entity 29559 29582	gene expression pattern
T487	Entity 29941 29966	gene expression profiling
T488	Entity 30175 30200	gene expression profiling
T489	Entity 30395 30411	small-effect QTL
T490	Entity 30627 30659	small-effect QTL candidate genes
T491	Entity 23179 23188	arthritis
T492	Entity 23190 23196	Mapk14
T493	Entity 23243 23292	p38 mitogen-activated protein kinase (MAPK) alpha
R66	other_relation Arg1:T492 Arg2:T493	
#15	AnnotatorNotes R66	equivalent
T494	Entity 23200 23214	candidate gene
T495	Entity 23308 23318;23322 23351	production arthritis-essential cytokines
T496	Entity 23361 23383	tumour necrosis factor
T497	Entity 23388 23401	interleukin-1
R67	is_subclass_of Arg1:T496 Arg2:T495	
R68	is_subclass_of Arg1:T497 Arg2:T495	
R69	regulates Arg1:T493 Arg2:T495	
T498	Entity 23418 23428;23432 23440	inhibitors p38 MAPK
T499	Entity 23479 23487	p38 MAPK
T500	Entity 23502 23530	potential therapeutic target
T501	Entity 23534 23536	RA
T502	Entity 23543 23549	Stat5a
T503	Entity 23609 23629	lymphoid development
T504	Entity 23609 23617;23634 23649	lymphoid differentiation
R70	regulates Arg1:T502 Arg2:T504	
R71	regulates Arg1:T502 Arg2:T503	
T505	Entity 23656 23677	Stat5a-deficient mice
T506	Entity 23700 23709	tolerance
T507	Entity 23728 23739;23743 23762	development autoimmune diseases
R72	other_relation Arg1:T507 Arg2:T505	
#16	AnnotatorNotes R72	phenotype
T508	Entity 23764 23770	Stat5a
T509	Entity 23801 23810	tolerance
T510	Entity 23838 23876	CD4+CD25+ regulatory T cell population
R73	participates_in Arg1:T508 Arg2:T509	
T511	Entity 23936 23952	small-effect QTL
T512	Entity 23968 23993	potential candidate genes
T513	Entity 24125 24147	false positive results
T514	Entity 24188 24204	small-effect QTL
T515	Entity 24269 24284	false positives
T516	Entity 24393 24406	arthritis QTL
T517	Entity 24548 24563	false positives
T518	Entity 24571 24601	differentially expressed genes
T519	Entity 24681 24698	allele difference
T520	Entity 24857 24872	candidate genes
T521	Entity 24877 24893	small-effect QTL
T522	Entity 24932 24947	candidate genes
T523	Entity 24954 24970	small-effect QTL
R74	regulates Arg1:T523 Arg2:T76	
T524	Entity 25076 25103	generating congenic animals
T525	Entity 25118 25134	small-effect QTL
T526	Entity 25209 25222	arthritis QTL
T527	Entity 25261 25276	candidate genes
T528	Entity 25313 25328	Candidate genes
T529	Entity 25365 25373	function
T530	Entity 25378 25390	polymorphism
T531	Entity 25445 25459	knock-out mice
T532	Entity 25571 25573	RA
T533	Entity 25599 25614	candidate genes
T534	Entity 25621 25653	case-control association studies
T535	Entity 25657 25667	RA cohorts
T536	Entity 26500 26530	genes differentially expressed
T537	Entity 26539 26544	DBA/1
T538	Entity 26549 26554	FVB/N
T539	Entity 26697 26727	differentially expressed genes
T540	Entity 27004 27034	genes differentially expressed
T541	Entity 27038 27044	joints
T542	Entity 27052 27057	DBA/1
T543	Entity 27126 27128	PI
T544	Entity 27077 27097	Pairwise comparisons
T545	Entity 27130 27132	OA
T546	Entity 27137 27139	CA
T547	Entity 27145 27147	NA
T548	Entity 27518 27558	strain-specific differentially expressed
T549	Entity 27568 27580	dysregulated
T550	Entity 27588 27593	DBA/1
T551	Entity 27894 27924	Differentially expressed genes
T552	Entity 28250 28268	naive control (NC)
T553	Entity 28289 28311	post-immunisation (PI)
T554	Entity 28336 28359	onset of arthritis (OA)
T555	Entity 28386 28408	chronic arthritis (CA)
T556	Entity 28457 28499	overlapping genes differentially expressed
R75	other_relation Arg1:T552 Arg2:T88	
#17	AnnotatorNotes R75	is_a_phase_of
R76	other_relation Arg1:T553 Arg2:T88	
#18	AnnotatorNotes R76	is_a_phase_of
R77	other_relation Arg1:T554 Arg2:T88	
#19	AnnotatorNotes R77	is_a_phase_of
R78	other_relation Arg1:T555 Arg2:T88	
#20	AnnotatorNotes R78	is_a_phase_of
T557	Entity 28539 28569	Differentially expressed genes
T558	Entity 28577 28582	DBA/1
T559	Entity 28637 28660	experimental conditions
T560	Entity 28662 28684	post-immunisation (PI)
T561	Entity 28686 28709	onset of arthritis (OA)
T562	Entity 28714 28736	chronic arthritis (CA)
T563	Entity 28757 28775	naïve control (NC)
T564	Entity 28790 28820	differentially expressed genes
T565	Entity 28826 28838	Venn diagram
T566	Entity 28864 28906	overlapping genes differentially expressed
T567	Entity 28935 28958	Hierarchical clustering
T568	Entity 28970 29000	differentially expressed genes
T569	Entity 29079 29106	hierarchical tree structure
T570	Entity 29324 29337	transcription
T571	Entity 29480 29493	gene clusters
T572	Entity 29599 29618	expression patterns
T573	Entity 29626 29638	gene cluster
T574	Entity 29726 29756	functional clustering analysis
R79	is_subclass_of Arg1:T560 Arg2:T559	
R80	is_subclass_of Arg1:T561 Arg2:T559	
R81	is_subclass_of Arg1:T562 Arg2:T559	
T575	Entity 29821 29842	chromosomal locations
T576	Entity 29850 29866	small-effect QTL
T577	Entity 30043 30046	QTL
T578	Entity 30113 30116	QTL
